• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO BYPASS SYSTEM; INTRAOCULAR PRESSURE LOWERING IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO BYPASS SYSTEM; INTRAOCULAR PRESSURE LOWERING IMPLANT Back to Search Results
Model Number G2-W-US
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/27/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that following a cataract surgery, the tip of the trocar broke during the implantation of the second stent from a trabecular microbypass stent system.The trocar fragment was removed intraoperatively from the patient's eye with no report of injury.Additional information has been requested.
 
Additional Manufacturer Narrative
Additional information: the device has been returned to glaukos for evaluation, and the investigation is ongoing.The device history record review of the manufacturing lot was performed and there were no non-conformities found to be related to the reported event.A complaint history review was completed.The electronic complaint system was searched for the specified lot#.There were no similar issues reported for this lot #.A review of the device labeling including the risk analysis was completed.The reported issue (trocar fragmentation) is identified to be an anticipated hazard.The residual risk for each potential harm was found to be within the insignificant risk region.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.Mfr# reference: 4(b)(4).
 
Additional Manufacturer Narrative
The injector was returned loose and wrapped in bubble wrap in the unsealed thermoform packaging tray.The device evaluation was completed, and the injector's frontal components were found bent, and the injector¿s trocar was found broken at the splay.These findings likely occurred due to both customer handling of the device and how the device was shipped back.The broken tip of the trocar was not returned.Conclusions based on the evaluation findings were confounded by the condition of the returned product.As a result, the root cause of the reported issue could not be conclusively identified.Mfr # reference: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISTENT INJECT W TRABECULAR MICRO BYPASS SYSTEM
Common Device Name
INTRAOCULAR PRESSURE LOWERING IMPLANT
Manufacturer (Section D)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer (Section G)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer Contact
brittany massey
229 avenida fabricante
san clemente, CA 92672
949367960
MDR Report Key21379730
Report Number2032546-2025-00022
Device Sequence Number8471412
Product Code OGO
UDI-Device Identifier00853704002319
UDI-Public01008537040023191031937317270228
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
P170043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/28/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberG2-W-US
Device Lot Number319373
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/03/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/28/2025
Supplement Date Received by Manufacturer03/27/2025
Initial Report FDA Received Date02/13/2025
Supplement Report FDA Received Date03/28/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/22/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-